Valley National Advisers Inc. Has $97,000 Stock Holdings in Cardinal Health, Inc. $CAH

Valley National Advisers Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 96.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 621 shares of the company’s stock after selling 15,709 shares during the period. Valley National Advisers Inc.’s holdings in Cardinal Health were worth $97,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of CAH. MassMutual Private Wealth & Trust FSB lifted its position in shares of Cardinal Health by 3.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after buying an additional 62 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in Cardinal Health by 0.4% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after acquiring an additional 69 shares in the last quarter. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the period. Perigon Wealth Management LLC boosted its stake in shares of Cardinal Health by 3.2% in the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after purchasing an additional 72 shares in the last quarter. Finally, Community Bank & Trust Waco Texas boosted its stake in shares of Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after purchasing an additional 74 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

CAH stock opened at $208.19 on Monday. The company has a 50 day moving average price of $196.29 and a 200 day moving average price of $170.26. Cardinal Health, Inc. has a fifty-two week low of $117.53 and a fifty-two week high of $214.93. The stock has a market capitalization of $49.46 billion, a PE ratio of 31.40, a price-to-earnings-growth ratio of 1.52 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period last year, the company earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several analyst reports. Robert W. Baird set a $232.00 price target on shares of Cardinal Health in a report on Friday, October 31st. Leerink Partners lifted their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Evercore ISI increased their price target on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. Argus raised their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Finally, TD Cowen lifted their price objective on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.